PHILADELPHIA — Early adjuvant use of opicapone (Ongentys) may reduce the risk for complications in patients with early Parkinson's disease (PD) and no motor complications. The US Food and Drug ...
Baltimore, Maryland (March 31, 2025) — The Lieber Institute for Brain Development, a nonprofit research institution dedicated to treating and preventing developmental brain disorders, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results